查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2054946

DNA甲基化市場：按產品/服務、技術、樣本類型、工作流程階段和應用分類

DNA Methylation Market, By Product and Service, By Technology, By Sample Type, By Workflow Stage, By Application (Clinical Applications, and Research Applications, By End User, By Testing Model, By Geography )
出版日期: | 出版商: Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

據估計，DNA甲基化市場在2026年的價值為20.1億美元，預計到2033年將達到51.6億美元。預計從2026年到2033年，其複合年成長率將達到14.4%。

報告範圍 報告詳情
基準年： 2025 2026年市場規模： 20.1億美元
歷史數據時期： 2020-2024 預測期： 2026-2033
2026年至2033年預測期間的複合年成長率： 14.40% 2033年市場規模預測： 51.6億美元

全球DNA甲基化市場是分子生物學和表觀遺傳學研究領域中一個快速成長的細分市場，其成長動力源自於人們日益認知到DNA甲基化在基因表現調控、疾病發展和治療性介入的關鍵作用。 DNA甲基化是一種基本的表觀遺傳修飾，其特徵是將甲基基團添加到DNA序列中的胞嘧啶鹼基上，它是一種在不改變遺傳密碼的情況下調控基因表現的重要機制。該市場涵蓋廣泛的產品和服務，例如甲基化分析試劑盒、定序平台、生物資訊軟體和專業實驗室服務，這些產品和服務使研究人員和臨床醫生能夠研究各種生物樣本中的甲基化模式。

隨著我們對DNA甲基化在癌症進展、神經系統疾病、心血管疾病和老化過程中的作用認知不斷加深，該領域的研究投入和商業性興趣顯著成長。全基因組亞硫酸氫鹽定序、甲基化特異性PCR和基於晶片的甲基化分析等先進技術，以前所未有的精度和處理能力，徹底革新了甲基化變化的檢測和定量能力。個人化醫療、生物標記發現、藥物研發和臨床診斷等領域的日益廣泛應用，進一步推動了市場擴張，使DNA甲基化分析成為現代生物學研究和精準醫療中不可或缺的工具。

市場動態

全球DNA甲基化市場正受到多個強勁促進因素的推動，這些因素支撐著其穩健的成長軌跡，其中最主要的是癌症研究的快速發展以及DNA甲基化作為早期疾病檢測和預後關鍵生物標記的日益普及。全球癌症發生率的上升，加上政府和私人機構對表觀遺傳學研究的大量投入，使得對先進的甲基化分析工具和技術的需求空前高漲。此外，DNA甲基化在個人化醫療、藥物研發，尤其是在製藥業對標靶治療的探索中應用範圍的不斷擴大，也顯著提升了市場滲透率。然而，該市場也面臨諸多限制因素。其中之一是先進的甲基化分析儀和試劑的高成本，這可能會限制預算有限的小規模研究機構和實驗室的使用。

甲基化資料解讀的複雜性以及對專業技術的需求是其應用面臨的主要障礙。許多機構缺乏有效利用這些先進技術所需的生物資訊基礎設施和熟練人員。此外，不同甲基化分析平台和調查方法之間的標準化挑戰可能導致結果不一致，這可能會阻礙其在臨床環境中的廣泛應用。儘管有這些限制，定序平台和調查方法的持續技術進步正使甲基化研究更加便捷高效，並帶來巨大的市場機會。人工智慧（AI）和機器學習在甲基化數據分析中的日益融合，預示著提高準確性和效率的良好前景。此外，其應用範圍從腫瘤學擴展到神經系統疾病、心血管疾病和老化研究等領域，正在創造具有巨大成長潛力的全新市場。同時，對液態生物檢體和非侵入性診斷方法的日益關注，也為DNA甲基化的臨床應用帶來了突破性的機會。

本研究的關鍵特徵

  • 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
  • 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數對全球 DNA 甲基化市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務表現和策略。
  • 本報告中的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球 DNA 甲基化市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用分析全球 DNA 甲基化市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章：研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章：市場動態、監管與趨勢分析

  • 市場動態
  • 促進因素
  • 抑制因子
  • 機會
  • 影響分析
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購情景
  • 產業趨勢

第4章 全球DNA甲基化市場：依產品/服務分類，2021-2033年

  • 試劑盒和試劑（亞硫酸氫鹽轉化、濃縮/捕獲、PCR/qPCR、對照/標準品）
  • 設備（NGS平台、PCR/qPCR系統、微陣列掃描器、焦磷酸定序儀）
  • 軟體和服務（分析和視覺化工具、雲端管道、客製化偵測設計、數據解釋）

第5章 全球DNA甲基化市場：依技術分類，2021-2033年

  • 亞硫酸氫鹽定序（WGBS、RRBS、對稱亞硫酸氫鹽定序）
  • 基於聚合酵素鏈鎖反應（PCR）的（MSP、qMSP、COBRA、HRM）
  • 富集方法（MeDIP-seq、MBD-seq、基於捕獲的panel）
  • 基於晶片的（Infinium/EPIC 型甲基化晶片）
  • 標靶檢測（焦磷酸測序、MassARRAY、數位PCR）
  • 長讀長定序與單分子定序（Nanopore Direct、SMRT Kinetics）

第6章 全球DNA甲基化市場：依樣本類型分類，2021-2033年

  • 組織（FFPE，新鮮/冷凍）
  • 液態生物檢體（血漿/血清cfDNA，全血/PBMC）
  • 非血液樣本（唾液/口腔黏膜、尿液、腦脊髓液）
  • 生殖細胞/生殖（精子、卵子）
  • 其他

第7章 全球DNA甲基化市場：依工作流程階段分類，2021-2033年

  • 檢體採集和DNA提取
  • 亞硫酸氫鹽轉化/化學處理
  • 濃縮/捕獲
  • 擴增和樣品製備
  • 定序/檢測
  • 生物資訊分析與報告生成

第8章 全球DNA甲基化市場：依應用領域分類，2021-2033年

  • 臨床應用
  • 研究用途

第9章 全球DNA甲基化市場：依最終用戶分類，2021-2033年

  • 學術研究機構
  • 醫院和臨床/診斷實驗室
  • 製藥和生物技術公司
  • 合約研究/中心檢查室和參考檢查室
  • 其他（法醫學實驗室）

第10章 全球DNA甲基化市場：依檢測模型分類，2021-2033年

  • 內部測試（現場實驗室）
  • 外包檢測（CRO/參考實驗室）

第11章 全球DNA甲基化市場：依地區分類，2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第12章 競爭格局

  • Illumina
  • Thermo Fisher Scientific
  • QIAGEN
  • Agilent Technologies
  • Merck KGaA（MilliporeSigma）
  • Zymo Research
  • New England Biolabs（NEB）
  • PerkinElmer
  • Abcam
  • Bio-Rad Laboratories
  • Pacific Biosciences（PacBio）
  • Oxford Nanopore Technologies
  • Roche
  • Active Motif
  • Diagenode（Hologic 的子公司）

第13章 分析師建議

  • 機會分析
  • 分析師意見
  • 一致的機會地圖

第14章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI8689

DNA Methylation Market is estimated to be valued at USD 2.01 Bn in 2026 and is expected to reach USD 5.16 Bn by 2033, growing at a compound annual growth rate (CAGR) of 14.4% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 2.01 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 14.40% 2033 Value Projection: USD 5.16 Bn

The global DNA methylation market represents a rapidly expanding segment within the molecular biology and epigenetics research landscape, driven by the increasing recognition of DNA methylation's critical role in gene regulation, disease development, and therapeutic interventions. DNA methylation, a fundamental epigenetic modification involving the addition of methyl groups to cytosine bases in DNA sequences, serves as a crucial mechanism for controlling gene expression without altering the underlying genetic code. This market encompasses a comprehensive range of products and services including methylation analysis kits, sequencing platforms, bioinformatics software, and specialized laboratory services that enable researchers and clinicians to investigate methylation patterns across various biological samples.

The growing understanding of DNA methylation's involvement in cancer progression, neurological disorders, cardiovascular diseases, and aging processes has significantly amplified research investments and commercial interest in this field. Advanced technologies such as whole-genome bisulfite sequencing, methylation-specific PCR, and array-based methylation analysis have revolutionized the ability to detect and quantify methylation changes with unprecedented accuracy and throughput. The market's expansion is further supported by increasing applications in personalized medicine, biomarker discovery, drug development, and clinical diagnostics, positioning DNA methylation analysis as an indispensable tool in modern biological research and precision healthcare initiatives.

Market Dynamics

The global DNA methylation market is propelled by several compelling drivers that collectively fuel its robust growth trajectory, with the primary catalyst being the exponential increase in cancer research and the growing recognition of DNA methylation as a critical biomarker for early disease detection and prognosis. The rising prevalence of cancer worldwide, coupled with substantial government funding and private investments in epigenetic research, has created unprecedented demand for advanced methylation analysis tools and technologies. Additionally, the expanding applications of DNA methylation in personalized medicine and drug development, particularly in the pharmaceutical industry's pursuit of targeted therapies, significantly drives market adoption. However, the market faces notable restraints including the high costs associated with advanced methylation analysis equipment and reagents, which can limit accessibility for smaller research institutions and laboratories with constrained budgets.

The complexity of methylation data interpretation and the requirement for specialized technical expertise present additional barriers, as many facilities lack the necessary bioinformatics infrastructure and skilled personnel to effectively utilize these sophisticated technologies. Furthermore, standardization challenges across different methylation analysis platforms and methodologies can create inconsistencies in results, potentially hindering widespread clinical adoption. Despite these constraints, the market presents substantial opportunities through the continuous technological advancements in sequencing platforms and analysis methods, which are making methylation studies more accessible and cost-effective. The growing integration of artificial intelligence and machine learning in methylation data analysis offers promising avenues for enhanced accuracy and efficiency. Moreover, the expanding applications beyond oncology into neurological disorders, cardiovascular diseases, and aging research create new market segments with significant growth potential, while the increasing focus on liquid biopsy and non-invasive diagnostic methods presents revolutionary opportunities for DNA methylation-based clinical applications.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global DNA methylation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Merck KGaA (MilliporeSigma), Zymo Research, New England Biolabs (NEB), PerkinElmer, Abcam, Bio-Rad Laboratories, Pacific Biosciences (PacBio), Oxford Nanopore Technologies, Roche, Active Motif, and Diagenode (a Hologic company)
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global DNA methylation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global DNA methylation market

Market Segmentation

  • Product and Service Insights (Revenue, USD Bn, 2021 - 2033)
  • Kits and Reagents (bisulfite conversion, enrichment/capture, PCR/qPCR, controls/standards)
  • Instruments (NGS platforms, PCR/qPCR systems, microarray scanners, pyrosequencers)
  • Software and Services (analysis/visualization tools, cloud pipelines, custom assay design, data interpretation)
  • Technology Insights (Revenue, USD Bn, 2021 - 2033)
  • Bisulfite-based sequencing (WGBS, RRBS, targeted bisulfite sequencing)
  • Polymerase Chain Reaction (PCR)-based (MSP, qMSP, COBRA, HRM)
  • Enrichment-based (MeDIP-seq, MBD-seq, capture-based panels)
  • Array-based (Infinium/EPIC-type methylation arrays)
  • Targeted detection (pyrosequencing, MassARRAY, digital PCR)
  • Long-read and single-molecule (Nanopore direct, SMRT kinetics)
  • Sample Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Tissue (FFPE, fresh/frozen)
  • Liquid biopsy (plasma/serum cfDNA, whole blood/PBMC)
  • Non-blood (saliva/buccal, urine, CSF)
  • Germline/reproductive (sperm, oocytes)
  • Others
  • Workflow Stage Insights (Revenue, USD Bn, 2021 - 2033)
  • Sample collection and DNA extraction
  • Bisulfite conversion/chemical treatment
  • Enrichment/capture
  • Amplification and library preparation
  • Sequencing/detection
  • Bioinformatics analysis and reporting
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Clinical Applications
    • Oncology Diagnostics & Prognostics
    • Non-Invasive Prenatal Testing (NIPT)
    • Genetic Disease Testing
    • Other Disease Diagnostics (e.g., Neurological, Infectious)
  • Research Applications
    • Biomarker Discovery
    • Developmental Biology
    • Drug Discovery & Development
    • Others (Animal Research)
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Academic and research institutes
  • Hospitals and clinical/diagnostic laboratories
  • Pharmaceutical and biotechnology companies
  • Contract research/central labs and reference labs
  • Others (Forensic laboratories)
  • Testing Model Insights (Revenue, USD Bn, 2021 - 2033)
  • In-house testing (onsite labs)
  • Outsourced testing (CROs/reference labs)
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Illumina
  • Thermo Fisher Scientific
  • QIAGEN
  • Agilent Technologies
  • Merck KGaA (MilliporeSigma)
  • Zymo Research
  • New England Biolabs (NEB)
  • PerkinElmer
  • Abcam
  • Bio-Rad Laboratories
  • Pacific Biosciences (PacBio)
  • Oxford Nanopore Technologies
  • Roche
  • Active Motif
  • Diagenode (a Hologic company)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global DNA Methylation Market, By Product and Service
    • Global DNA Methylation Market, By Technology
    • Global DNA Methylation Market, By Sample Type
    • Global DNA Methylation Market, By Workflow Stage
    • Global DNA Methylation Market, By Application
    • Global DNA Methylation Market, By End User
    • Global DNA Methylation Market, By Testing Model
    • Global DNA Methylation Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global DNA Methylation Market, By Product and Service, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Kits and Reagents (bisulfite conversion, enrichment/capture, PCR/qPCR, controls/standards)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Instruments (NGS platforms, PCR/qPCR systems, microarray scanners, pyrosequencers)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Software and Services (analysis/visualization tools, cloud pipelines, custom assay design, data interpretation)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global DNA Methylation Market, By Technology, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Bisulfite-based sequencing (WGBS, RRBS, targeted bisulfite sequencing)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Polymerase Chain Reaction (PCR)-based (MSP, qMSP, COBRA, HRM)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Enrichment-based (MeDIP-seq, MBD-seq, capture-based panels)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Array-based (Infinium/EPIC-type methylation arrays)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Targeted detection (pyrosequencing, MassARRAY, digital PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Long-read and single-molecule (Nanopore direct, SMRT kinetics)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global DNA Methylation Market, By Sample Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Tissue (FFPE, fresh/frozen)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Liquid biopsy (plasma/serum cfDNA, whole blood/PBMC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Non-blood (saliva/buccal, urine, CSF)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Germline/reproductive (sperm, oocytes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global DNA Methylation Market, By Workflow Stage, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Sample collection and DNA extraction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Bisulfite conversion/chemical treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Enrichment/capture
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Amplification and library preparation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Sequencing/detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Bioinformatics analysis and reporting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global DNA Methylation Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Clinical Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Oncology Diagnostics & Prognostics
      • Non-Invasive Prenatal Testing (NIPT)
      • Genetic Disease Testing
      • Other Disease Diagnostics (e.g., Neurological, Infectious)
  • Research Applications
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Biomarker Discovery
      • Developmental Biology
      • Drug Discovery & Development
      • Others (Animal Research)

9. Global DNA Methylation Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • Academic and research institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Hospitals and clinical/diagnostic laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pharmaceutical and biotechnology companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Contract research/central labs and reference labs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (Forensic laboratories)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global DNA Methylation Market, By Testing Model, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022- 2033
    • Segment Trends
  • In-house testing (onsite labs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Outsourced testing (CROs/reference labs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

11. Global DNA Methylation Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product and Service, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Workflow Stage, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Testing Model, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

12. Competitive Landscape

  • Illumina
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA (MilliporeSigma)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zymo Research
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • New England Biolabs (NEB)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abcam
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pacific Biosciences (PacBio)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oxford Nanopore Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Active Motif
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Diagenode (a Hologic company)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

13. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

14. References and Research Methodology

  • References
  • Research Methodology
  • About us